Cardiovascular prevention in HIV-positive individuals on antiretroviral therapy.. The paradigm shift has already happened: Is it time to wake up and realise it?
Grigioni, F.; Calza, L.
European Journal of Preventive Cardiology 24(13): 1381-1382
2017
ISSN/ISBN: 2047-4873
PMID: 28644094
DOI: 10.1177/2047487317717066
Accession: 059471974
PDF emailed within 0-6 h: $19.90
Related References
van Zoest, R.A.; van der Valk, M.; Wit, F.W.; Vaartjes, I.; Kooij, K.W.; Hovius, J.W.; Prins, M.; Reiss, P. 2017: Suboptimal primary and secondary cardiovascular disease prevention in HIV-positive individuals on antiretroviral therapy European Journal of Preventive Cardiology 24(12): 1297-1307Seufert, J. 2009: The backbone of oral glucose-lowering therapy: time for a paradigm shift? : Cardiovascular drug therapy for cardiovascular protection Educational Autumn Meeting 23(6): 651-667
Seremba, E.; Ssempijja, V.; Kalibbala, S.; Gray, R.H.; Wawer, M.J.; Nalugoda, F.; Casper, C.; Phipps, W.; Ocama, P.; Serwadda, D.; Thomas, D.L.; Reynolds, S.J. 2017: Hepatitis B incidence and prevention with antiretroviral therapy among HIV-positive individuals in Uganda Aids 31(6): 781-786
Cade, W.T.; Reeds, D.N.; Lassa-Claxton, S.; Davila-Roman, V.G.; Waggoner, A.D.; Powderly, W.G.; Yarasheski, K.E. 2008: Post-exercise heart rate recovery in HIV-positive individuals on highly active antiretroviral therapy. Early indicator of cardiovascular disease? HIV Medicine 9(2): 96-100
Whitlock, G.G.; Patel, A.; Edwards, S.G.; Benn, P.D.; Miller, R.F. 2012: The current system for prescribing antiretroviral therapy puts HIV-infected patients at risk of serious drug-drug interactions: is now the time for a paradigm shift in HIV care delivery? Clinical Medicine 12(3): 300-301
Hu, F.B. 2007: Diet and cardiovascular disease prevention the need for a paradigm shift Journal of the American College of Cardiology 50(1): 22-24
Pellanda, L.Campos. 2011: Early determinants of cardiovascular diseases in the life course: a paradigm shift to prevention Revista da Associacao Medica Brasileira 57(6): 608-609
Wanchu, A.; Suresh, P. 2007: Testing for HIV infection in high-risk individuals: time for a paradigm shift? Journal of Acquired Immune Deficiency Syndromes 44(2): 244-246
Poudel, K.C.; Buchanan, D.R.; Poudel-Tandukar, K. 2016: Delays in antiretroviral therapy initiation among HIV-positive individuals: results of the positive living with HIV study Global Health Action 9: 31550
Poudel, K.C.; Buchanan, D.R.; Poudel-Tandukar, K. 2017: Delays in antiretroviral therapy initiation among HIV-positive individuals: results of the positive living with HIV study Global Health Action 9(1): 31550-31550
Benharash, P.; Frank, P.; Hoy, B. 2012: Development and use of a novel cardiovascular simulator: time for a paradigm shift? American Surgeon 78(10): 1132-1136
Kunisaki, K.M.; Niewoehner, D.E.; Collins, G.; Aagaard, B.; Atako, N.B.; Bakowska, E.; Clarke, A.; Corbelli, G.Maria.; Ekong, E.; Emery, S.; Finley, E.B.; Florence, E.; Infante, R.M.; Kityo, C.M.; Madero, J.Sierra.; Nixon, D.E.; Tedaldi, E.; Vestbo, Jørgen.; Wood, R.; Connett, J.E. 2016: Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial Lancet. Respiratory Medicine 4(12): 980-989
Baker, J.V.; Sharma, S.; Achhra, A.C.; Bernardino, J.Ignacio.; Bogner, J.R.; Duprez, D.; Emery, S.; Gazzard, B.; Gordin, J.; Grandits, G.; Phillips, A.N.; Schwarze, S.; Soliman, E.Z.; Spector, S.A.; Tambussi, G.; Lundgren, J. 2017: Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial Journal of the American Heart Association 6(5)
Raboud, J.; Blitz, S.; Walmsley, S.; Thompson, C.; Rourke, S.B.; Loutfy, M.R.; Rourke, S.B.; Bayoumi, A.; Burchell, A.; Cohen, J.; Cooper, C.; Crouzat, F.; Gardner, S.; Kilby, D.; Logue, K.; Loutfy, M.; Mittmann, N.; Raboud, J.; Rachlis, A.; Ralph, E.; Rueda, S.; Salit, I.; Sandre, R.; Smieja, M.; Wobeser, W.; Taylor, D.; Collins, E.; Robinson, G.; Margolese, S.; Cupido, P.; Di Pede, T.; Kennedy, R.; Hamilton, M.; King, K.; Finch, B.; Stoltz, L.; Bayoumi, A.; George, C.; Cooper, C.; Fisher, M.; Waring, V. 2010: Effect of gender and calendar year on time to and duration of virologic suppression among antiretroviral-naïve HIV-infected individuals initiating combination antiretroviral therapy HIV clinical trials 11(6): 340-350
Joshi, P.H.; Nasir, K. 2015: The highs and lows of cardiovascular risk prediction: time for paradigm shift? Atherosclerosis 239(2): 436-438